263 related articles for article (PubMed ID: 33917029)
1. Altered Profile of E1-S Transporters in Endometrial Cancer: Lower Protein Levels of ABCG2 and OSTβ and Up-Regulation of
Pavlič R; Vidic S; Anko M; Knific T; Büdefeld T; Marton K; Sinreih M; Poschner S; Jäger W; Frković-Grazio S; Rižner TL
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917029
[TBL] [Abstract][Full Text] [Related]
2. The endometrial cancer cell lines Ishikawa and HEC-1A, and the control cell line HIEEC, differ in expression of estrogen biosynthetic and metabolic genes, and in androstenedione and estrone-sulfate metabolism.
Hevir-Kene N; Rižner TL
Chem Biol Interact; 2015 Jun; 234():309-19. PubMed ID: 25437045
[TBL] [Abstract][Full Text] [Related]
3. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.
Yamada A; Maeda K; Kamiyama E; Sugiyama D; Kondo T; Shiroyanagi Y; Nakazawa H; Okano T; Adachi M; Schuetz JD; Adachi Y; Hu Z; Kusuhara H; Sugiyama Y
Drug Metab Dispos; 2007 Dec; 35(12):2166-76. PubMed ID: 17823233
[TBL] [Abstract][Full Text] [Related]
4. OATP1B3-1B7, a novel organic anion transporting polypeptide, is modulated by FXR ligands and transports bile acids.
Malagnino V; Hussner J; Issa A; Midzic A; Meyer Zu Schwabedissen HE
Am J Physiol Gastrointest Liver Physiol; 2019 Dec; 317(6):G751-G762. PubMed ID: 31509437
[TBL] [Abstract][Full Text] [Related]
5. Expression of organic anion-transporting polypeptides 1B1 and 1B3 in ovarian cancer cells: relevance for paclitaxel transport.
Svoboda M; Wlcek K; Taferner B; Hering S; Stieger B; Tong D; Zeillinger R; Thalhammer T; Jäger W
Biomed Pharmacother; 2011 Sep; 65(6):417-26. PubMed ID: 21719246
[TBL] [Abstract][Full Text] [Related]
6. Differential role of organic anion-transporting polypeptides in estrone-3-sulphate uptake by breast epithelial cells and breast cancer cells.
Banerjee N; Allen C; Bendayan R
J Pharmacol Exp Ther; 2012 Aug; 342(2):510-9. PubMed ID: 22588260
[TBL] [Abstract][Full Text] [Related]
7. Organic anion transporting polypeptide 2B1 and breast cancer resistance protein interact in the transepithelial transport of steroid sulfates in human placenta.
Grube M; Reuther S; Meyer Zu Schwabedissen H; Köck K; Draber K; Ritter CA; Fusch C; Jedlitschky G; Kroemer HK
Drug Metab Dispos; 2007 Jan; 35(1):30-5. PubMed ID: 17020956
[TBL] [Abstract][Full Text] [Related]
8. The effect of breast cancer resistance protein, multidrug resistant protein 1, and organic anion-transporting polypeptide 1B3 on the antitumor efficacy of the lipophilic camptothecin 7-t-butyldimethylsilyl-10-hydroxycamptothecin (AR-67) in vitro.
Tsakalozou E; Adane ED; Kuo KL; Daily A; Moscow JA; Leggas M
Drug Metab Dispos; 2013 Jul; 41(7):1404-13. PubMed ID: 23620484
[TBL] [Abstract][Full Text] [Related]
9. Contribution of hepatic organic anion-transporting polypeptides to docetaxel uptake and clearance.
Lee HH; Leake BF; Teft W; Tirona RG; Kim RB; Ho RH
Mol Cancer Ther; 2015 Apr; 14(4):994-1003. PubMed ID: 25695959
[TBL] [Abstract][Full Text] [Related]
10. Expression of membrane transporters and metabolic enzymes involved in estrone-3-sulphate disposition in human breast tumour tissues.
Banerjee N; Miller N; Allen C; Bendayan R
Breast Cancer Res Treat; 2014 Jun; 145(3):647-61. PubMed ID: 24831777
[TBL] [Abstract][Full Text] [Related]
11. Human organic anion transporter 1B1 and 1B3 function as bidirectional carriers and do not mediate GSH-bile acid cotransport.
Mahagita C; Grassl SM; Piyachaturawat P; Ballatori N
Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G271-8. PubMed ID: 17412826
[TBL] [Abstract][Full Text] [Related]
12. Association of genetic polymorphisms in the influx transporter SLCO1B3 and the efflux transporter ABCB1 with imatinib pharmacokinetics in patients with chronic myeloid leukemia.
Yamakawa Y; Hamada A; Nakashima R; Yuki M; Hirayama C; Kawaguchi T; Saito H
Ther Drug Monit; 2011 Apr; 33(2):244-50. PubMed ID: 21311410
[TBL] [Abstract][Full Text] [Related]
13. Steroid hormones specifically modify the activity of organic anion transporting polypeptides.
Koenen A; Köck K; Keiser M; Siegmund W; Kroemer HK; Grube M
Eur J Pharm Sci; 2012 Nov; 47(4):774-80. PubMed ID: 22982504
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a potential transporter-mediated drug interaction between rosuvastatin and pradigastat, a novel DGAT-1 inhibitor.
Kulmatycki K; Hanna I; Meyers D; Salunke A; Movva A; Majumdar T; Natrillo A; Vapurcuyan A; Rebello S; Sunkara G; Chen J
Int J Clin Pharmacol Ther; 2015 May; 53(5):345-55. PubMed ID: 25740267
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization for polymorphic organic anion transporting polypeptides (OATP/SLCO1B1, 1B3, 2B1) of monkeys recombinantly expressed with various OATP probes.
Takahashi T; Uno Y; Yamazaki H; Kume T
Biopharm Drug Dispos; 2019 Feb; 40(2):62-69. PubMed ID: 30652318
[TBL] [Abstract][Full Text] [Related]
16. Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist of the angiotensin II AT1-receptor, in humans.
Yamashiro W; Maeda K; Hirouchi M; Adachi Y; Hu Z; Sugiyama Y
Drug Metab Dispos; 2006 Jul; 34(7):1247-54. PubMed ID: 16624871
[TBL] [Abstract][Full Text] [Related]
17. Organic Anion Transporting Polypeptide-Mediated Hepatic Uptake of Glucuronide Metabolites of Androgens.
Li CY; Gupta A; Gáborik Z; Kis E; Prasad B
Mol Pharmacol; 2020 Sep; 98(3):234-242. PubMed ID: 32587096
[TBL] [Abstract][Full Text] [Related]
18. Fluorescent probes for the dual investigation of MRP2 and OATP1B1 function and drug interactions.
Székely V; Patik I; Ungvári O; Telbisz Á; Szakács G; Bakos É; Özvegy-Laczka C
Eur J Pharm Sci; 2020 Aug; 151():105395. PubMed ID: 32473861
[TBL] [Abstract][Full Text] [Related]
19. Characterization of OATP1B3 and OATP2B1 transporter expression in the islet of the adult human pancreas.
Kim M; Deacon P; Tirona RG; Kim RB; Pin CL; Meyer Zu Schwabedissen HE; Wang R; Schwarz UI
Histochem Cell Biol; 2017 Oct; 148(4):345-357. PubMed ID: 28493059
[TBL] [Abstract][Full Text] [Related]
20. The potential of Sutherlandia frutescens for herb-drug interaction.
Fasinu PS; Gutmann H; Schiller H; James AD; Bouic PJ; Rosenkranz B
Drug Metab Dispos; 2013 Feb; 41(2):488-97. PubMed ID: 23209194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
